Subot, Bb Girl .

HRN: 23-38-04  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/21/2023
AMPICILLIN 250MG (VIAL)
08/21/2023
08/27/2023
IV
120 Mg
Q12
Preterm
Waiting Final Action 
08/21/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/21/2023
08/27/2023
IV
18m G
Q8
Preterm
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: